Hematopoyetic and lymphoid tumors

Anna Sureda Balari

PRINCIPAL INVESTIGATORS
  • Concepcion Boque Genovart
  • Montserrat Arnan Sangerman
  • Santiago Mercadal Vilchez
  • Eva Domingo Domenech
  • Victoria Clapes Puig
  • Isabel Sanchez-Ortega Sanchez
  • Eva Gonzalez Barca
  • Monica Mansilla Suarez
  • Octavio Servitje Bedate
CLINICAL RESEARCHERS
  • Clara Maluquer Artigal
  • Alberto Mussetti
  • Anna Carla Oliveira Ramos
  • Sergio Cano Olivar
  • Maria Queralt Salas Gay
COLLABORATORS
  • Gabriela Elizabeth Bustamante Ramirez
POSTDOCTORAL RESEARCHERS (R2)
  • Maria Cristina Marin Monerris
PREDOCTORAL RESEARCHERS (R1)
  • Maria Cecilia Vilas
SCIENTIFIC SUPPORT
  • Beatriz Patiño Gutierrez
  • Rocio Parody Porras
MANAGEMENT SUPPORT
  • Silvia Murcia Muñoz
  • Miriam Ratia Garcia
  • Maria Emma Montenegro Rey
  • Meriem Kara
  • Miriam Espinosa Leiva
  • Damir Emanuel Blazevic Limone
Cancer
Oncobell

Scientific production

74

PAPERS

Impact factor: 428,041

16 PUBLICATIONS IN FIRST DECILE

43 PUBLICATIONS IN FIRST QUARTILE

Selected publications

  • Salles, Gilles; Duell, Johannes; Gonzalez Barca, Eva; Tournilhac, Olivier; Jurczak, Wojciech; Liberati, Anna Marina; Nagy, Zsolt; Obr, Ales; Gaidano, Gianluca; Andre, Marc; Kalakonda, Nagesh; Dreyling, Martin; Weirather, Johannes; Dirnberger-Hertweck, Maren; Ambarkhane, Sumeet; Fingerle-Rowson, Gunter; Maddocks, Kami. Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study. LANCET ONCOLOGY. 10.1016/S1470-2045(20)30225-4
  • Fatobene G, Rocha V, St Martin A, Hamadani M, Robinson S, Bashey A, Boumendil A, Brunstein C, Castagna L, Dominietto A, Finel H, Chalandon Y, Kenzey C, Kharfan-Dabaja M, Labussière-Wallet H, Moraleda JM, Pastano R, Perales MA, El Ayoubi HR, Ruggeri A, Sureda A, Volt F, Yakoub-Agha I, Zhang MJ, Gluckman E, Montoto S, Eapen M . Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR. JOURNAL OF CLINICAL ONCOLOGY. 10.1200/jco.19.02408
  • Pinato, David J.; Zambelli, Alberto; Aguilar-Company, Juan; Bower, Mark; Sng, Christopher C. T.; Salazar, Ramon; Bertuzzi, Alexia; Brunet, Joan; Mesia, Ricard; Segui, Elia; Biello, Federica; Generali, Daniele; Grisanti, Salvatore; Rizzo, Gianpiero; Libertini, Michela; Maconi, Antonio; Harbeck, Nadia; Vincenzi, Bruno; Bertulli, Rossella; Ottaviani, Diego; Carbo, Anna; Bruna, Riccardo; Benafif, Sarah; Marrari, Andrea; Wuerstlein, Rachel; Carmona-Garcia, M. Carmen; Chopra, Neha; Tondini, Carlo; Mirallas, Oriol; Tovazzi, Valeria; Betti, Marta; Provenzano, Salvatore; Fotia, Vittoria; Cruz, Claudia Andrea; Dalla Pria, Alessia; D’Avanzo, Francesca; Evans, Joanne S.; Saoudi-Gonzalez, Nadia; Felip, Eudald; Galazi, Myria; Garcia-Fructuoso, Isabel; Lee, Alvin J. X.; Newsom-Davis, Thomas; Patriarca, Andrea; Garcia-Illescas, David; Reyes, Roxana; Dileo, Palma; Sharkey, Rachel; Wong, Yien Ning Sophia; Ferrante, Daniela; Marco-Hernandez, Javier; Sureda, Anna; Maluquer, Clara; Ruiz-Camps, Isabel; Gaidano, Gianluca; Rimassa, Lorenza; Chiudinelli, Lorenzo; Izuzquiza, Macarena; Cabirta, Alba; Franchi, Michela; Santoro, Armando; Prat, Aleix; Tabernero, Josep; Gennari, Alessandra. Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer. CANCER DISCOVERY. 10.1158/2159-8290.CD-20-0773
  • Perez, Cristina; Botta, Cirino; Zabaleta, Aintzane; Puig, Noemi; Cedena, Maria-Teresa; Goicoechea, Ibai; Alameda, Daniel; San Jose-Eneriz, Edurne; Merino, Juana; Rodriguez-Otero, Paula; Maia, Catarina; Alignani, Diego; Maiso, Patricia; Manrique, Irene; Lara-Astiaso, David; Vilas-Zornoza, Amaia; Sarvide, Sarai; Riillo, Caterina; Rossi, Marco; Rosinol, Laura; Oriol, Albert; Blanchard, Maria-Jesus; Rios, Rafael; Sureda, Anna; Martin, Jesus; Martinez, Rafael; Bargay, Joan; de la Rubia, Javier; Hernandez, Miguel-Teodoro; Martinez-Lopez, Joaquin; Orfao, Alberto; Agirre, Xabier; Prosper, Felipe; Mateos, Maria-Victoria; Lahuerta, Juan-Jose; Blade, Joan; San-Miguel, Jesus F.; Paiva, Bruno. Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma. BLOOD. 10.1182/blood.2019004537
  • Bartlett, Nancy L.; Herrera, Alex F.; Domingo-Domenech, Eva; Mehta, Amitkumar; Forero-Torres, Andres; Garcia-Sanz, Ramon; Armand, Philippe; Devata, Sumana; Izquierdo, Antonia Rodriguez; Lossos, Izidore S.; Reeder, Craig; Sher, Taimur; Chen, Robert; Schwarz, Sylvia E.; Alland, Leila; Strassz, Andras; Prier, Kim; Choe-Juliak, Cassandra; Ansell, Stephen M.. A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma. BLOOD. 10.1182/blood.2019004701

Research highlights

PROJECTS

1 Ongoing project

 

124 Ongoing clinical trials

23 Started clinical trials

PUBLISHED WORKS

6 Clinical guidelines

3 Ongoing theses

Selected projects

  • Estudio abierto, de primera administración en humanos, agente único, con aumento escalonado de la dosis y expansión para evaluar la seguridad, farmacocinética, farmacodinámica y actividad antitumoral de SAR442085 en pacientes con mieloma múltiple en recaída o refractario (MMRR) (2019 – 2020) PI: SUREDA BALARI, ANA MARIA. Funder ref.: TED16132.
  • A phase 1 study to investigate the safety, pharmacokinetic profiles and the efficacy of EDO-S101, a first-in-class alkylating histone deacetylase inhibition (HDACi) fusion molecule, in relapsed/refractrory hematologi malgnancies (2020 – 2021) PI: SUREDA BALARI, ANA MARIA. Funder ref.: EDO-S101-1001.
  • Safety and efficacy of GEN3009 (DUOHEXABODY®-CD37) in relapsed or refractory b-cell non-hodgkin lymphoma – a first-in-human, open-label, phase I/IIA dose escalation trial with dose expansion cohorts (2020 – 2021) PI: SUREDA BALARI, ANA MARIA. Funder ref.: GCT3009.
  • A Phase 3, double-blind, placebo-controlled study of quizartinib (AC220) administered in combination with induction and consolidation chemotherapy, and administered as maintenance therapy in subjects 18 to 75 years old with newly diagnosed FLT3-ITD (+) acute myeloid leukemia (QUANTUM FIRST) (2017 – 2026) PI: ARNAN SANGERMAN, MONTSERRAT. Funder: DAIICHI SANKYO ESPAÑA, S.A.U.
  • A phase 1/2, open-label, dose-escalation trial of GEN3013 in patients with relapsed, progressive or refractory b-cell lymphoma (2019 – 2020) PI: SUREDA BALARI, ANA MARIA. Funder ref.: GCT3013-01.